|
Value-added
Business has become tougher, customers more choosy and competition
more intense. But with the increased complexity, formidable
hurdles and knowledge intensity, Indian pharmaceutical industry
is moving up the value curve. What does this value chain mean
to the industry? Sushmi Dey explores
Going
places
From a two-room kitchen company to a CRO, which provides full
range of services in clinical research, Synchron has come
a long way. With many effective business strategies, focus
and originality, the company has stood out. Sushmi Dey explores.
Rating
a CRO
Dr Rajam Jaishankar gives an overview on how sponsors can
assess the performance of current or potential CRO partners.
Fizz
that cures
Eno, one of the heritage brands from the GSK Consumer Healthcare
stable, now has Eno Pudina for company to fight against acidity,
marking its entry in the ayurvedic segment. Vanessa Mahapatra
finds out.
Trial
and error
Nick Burrows gives an account of some errors that led to wrong
judgements in some important patent challenges.
|